Brief: Cytomx Therapeutics To Outline 2023 Company Priorities And Provide Pipeline Update On January 5, 2023
22/12/2022 22:01
Dec 22 (Reuters) - CytomX Therapeutics Inc CTMX.O :
* CYTOMX THERAPEUTICS TO OUTLINE 2023 COMPANY PRIORITIES AND
PROVIDE PIPELINE UPDATE ON JANUARY 5, 2023
Source text for Eikon: ID:nGNX9jtTjg
Further company coverage: CTMX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CytomX Therapeutics
See all newsCytomX Q2 revenue misses, partly hurt by lower research activities in the Astellas collaboration
CytomX Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Cytomx Therapeutics Announces Appointment Of Charles Fuchs, M.D., M.P.H., To The Board Of Directors
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway